{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:04:31Z","timestamp":1768413871168,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejim.2013.03.019","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T15:49:50Z","timestamp":1366645790000},"page":"698-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Circadian rhythms and medical diseases: Does it matter when drugs are taken?"],"prefix":"10.1016","volume":"24","author":[{"given":"Alfredo","family":"De Giorgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Mallozzi Menegatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Fabbian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Portaluppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.03.019_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/physiolgenomics.2000.3.2.59","article-title":"Circadian rhythms in a nutshell","volume":"3","author":"Edery","year":"2000","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.ejim.2013.03.019_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCRESAHA.109.209957","article-title":"The cardiomyocyte circadian clock. Emerging roles in health and disease","volume":"106","author":"Durgan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2013.03.019_bb0015","series-title":"Fundamentals and applications of controlled release drug delivery","first-page":"359","article-title":"Biological rhythms, drug delivery, and chronotherapeutics","author":"Smolensky","year":"2012"},{"key":"10.1016\/j.ejim.2013.03.019_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/07420529908998710","article-title":"From a static to a dynamic concept of risk: the circadian epidemiology of cardiovascular events","volume":"16","author":"Portaluppi","year":"1999","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.addr.2006.08.003","article-title":"Circadian variation of blood pressure: the basis for the chronotherapy of hypertension","volume":"59","author":"Hermida","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejim.2013.03.019_bb0030","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","article-title":"Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study","volume":"27","author":"Hermida","year":"2010","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.1996.tb26713.x","article-title":"Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms","volume":"783","author":"Manfredini","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejim.2013.03.019_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/07420528.2012.715843","article-title":"24-hour pattern in the occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease","volume":"30","author":"Manfredini","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/HYPERTENSIONAHA.109.130203","article-title":"Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing","volume":"54","author":"Hermida","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2013.03.019_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/clpt.1993.129","article-title":"Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration","volume":"54","author":"Witte","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0055","first-page":"75","article-title":"Comparing different treatment schedules of Zomen (Zofenopril)","volume":"49","author":"B\u0103lan","year":"2011","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.ejim.2013.03.019_bb0060","first-page":"295","article-title":"Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring","volume":"3","author":"Palatini","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004872-199715020-00012","article-title":"The effect on 24h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night","volume":"15","author":"Morgan","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/07420520802548135","article-title":"Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients","volume":"26","author":"Hermida","year":"2009","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.HYP.0000084855.32823.DA","article-title":"Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects","volume":"42","author":"Hermida","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2013.03.019_bb0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.107.094235","article-title":"Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension","volume":"50","author":"Hermida","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2013.03.019_bb0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/07420520701420683","article-title":"Dose and administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects","volume":"24","author":"Hermida","year":"2007","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0090","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/ajh.2008.216","article-title":"Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing","volume":"21","author":"Hermida","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0095","first-page":"17","article-title":"Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients","volume":"3","author":"Nold","year":"1998","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.ejim.2013.03.019_bb0100","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/00004872-199312000-00013","article-title":"The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening","volume":"11","author":"Mengden","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0895-7061(95)00124-8","article-title":"Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure","volume":"8","author":"Portaluppi","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0895-7061(99)00044-8","article-title":"Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate","volume":"12","author":"White","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0115","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/07420520802544589","article-title":"Comparison of the effect on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension","volume":"25","author":"Hermida","year":"2008","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jash.2011.09.001","article-title":"Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients","volume":"6","author":"Acelajado","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1524-6175.2005.04304.x","article-title":"Comparison of a chronotherapeutically administered beta blocker vs. a traditionally administered beta blocker in patients with hypertension","volume":"7","author":"Neutel","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ejim.2013.03.019_bb0130","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ajh\/7.9.844","article-title":"Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT study","volume":"7","author":"Pickering","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3109\/10641961003667948","article-title":"The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine\u2013olmesartan combination therapy","volume":"32","author":"Hoshino","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ejim.2013.03.019_bb0140","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3109\/07420528.2010.489167","article-title":"Chronotherapy with valsartan\/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing","volume":"27","author":"Hermida","year":"2010","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0145","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/hr.2011.36","article-title":"Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing\u2014a multicenter, open-label randomized study","volume":"34","author":"Zeng","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ejim.2013.03.019_bb0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/07420528.2011.589935","article-title":"Chronotherapy with valsartan\/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing","volume":"28","author":"Hermida","year":"2011","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MBP.0b013e328344c6db","article-title":"Efficacy of morning and evening dosing of amlodipine\/valsartan combination in hypertensive patients uncontrolled by 5mg of amlodipine","volume":"16","author":"Asmar","year":"2011","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.ejim.2013.03.019_bb0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/07420529109059186","article-title":"Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing","volume":"8","author":"Middeke","year":"1991","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0165","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2011040361","article-title":"Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD","volume":"22","author":"Hermida","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/07420528.2012.702587","article-title":"Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes","volume":"30","author":"Moy\u00e1","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0175","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.11.4.816","article-title":"Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study","volume":"11","author":"Saito","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ejim.2013.03.019_bb0180","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/bmj.327.7418.788","article-title":"Taking simvastatin in the morning compared with in the evening: randomised controlled trial","volume":"327","author":"Wallace","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.03.019_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000093200","article-title":"Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration","volume":"106","author":"Scharnagl","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.ejim.2013.03.019_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5414\/CPP45328","article-title":"Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics","volume":"45","author":"Fauler","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/j.1552-4604.1996.tb04224.x","article-title":"Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening","volume":"36","author":"Cilla","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0200","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2146\/ajhp050072","article-title":"Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia","volume":"62","author":"Plakogiannis","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2013.03.019_bb0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2125.2002.01688.x","article-title":"Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers","volume":"54","author":"Martin","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/clc.4960150607","article-title":"Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance","volume":"15","author":"Roth","year":"1992","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0215","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1G659","article-title":"Optimal low-density cholesterol lowering \u2014 morning versus evening statin administration","volume":"41","author":"Plakogiannis","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2013.03.019_bb0220","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1345\/aph.1P511","article-title":"Comparison of effects of morning versus evening administration of ezetimibe\/simvastatin on serum cholesterol in patients with primary hypercholesterolemia","volume":"45","author":"Yoon","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2013.03.019_bb0225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ajem.2004.08.014","article-title":"Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls","volume":"22","author":"Manfredini","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ejim.2013.03.019_bb0230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archneur.59.1.48","article-title":"Patient demographic and clinical features and circadian variation in onset of ischemic stroke","volume":"59","author":"Casetta","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0235","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.287.10.1266","article-title":"Circadian variability in hemorrhagic stroke","volume":"287","author":"Casetta","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.03.019_bb0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07420529009056976","article-title":"Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects","volume":"7","author":"Haus","year":"1990","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.96.1.19","article-title":"Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin\u2013plasmin inhibitor complex","volume":"96","author":"Kapiotis","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.03.019_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/bmj.290.6465.341","article-title":"Circadian changes in anticoagulant effect of heparin infused at a constant rate","volume":"290","author":"Decousus","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.ejim.2013.03.019_bb0255","first-page":"557","article-title":"Chronopharmacology of fractionated heparin (nadroparin) administrated by subcutaneous route at prophylactic doses in healthy volunteers","volume":"47","author":"Mismetti","year":"1992","journal-title":"Therapie"},{"key":"10.1016\/j.ejim.2013.03.019_bb0260","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0038-1649794","article-title":"Chrono-pahramacological study of once daily curative dose of a low molecular weight heparin (200IU antiXa\/Kg of Dalteparin) in ten healthy volunteers","volume":"74","author":"Mismetti","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.03.019_bb0265","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/j.1875-9114.1995.tb02886.x","article-title":"Variations in prothrombin time and international normalized ratio over 24hours in warfarin-treated patients","volume":"15","author":"Bleske","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2013.03.019_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0049-3848(02)00339-0","article-title":"Variations of prothrombin time and international normalized ratio in patients treated with warfarin","volume":"107","author":"Ho","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2013.03.019_bb0275","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.STR.0000147155.08852.12","article-title":"Aspirin for stroke prevention taken in the evening?","volume":"35","author":"Kriszbacher","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2013.03.019_bb0280","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejpain.2010.11.014","article-title":"Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model","volume":"15","author":"Campbell","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ejim.2013.03.019_bb0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1981.tb01153.x","article-title":"Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day","volume":"11","author":"Kowanko","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0290","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/ard.61.12.1075","article-title":"Rhythmic variation in pain, stiffness, and manual dexterity in hand osteoarthritis","volume":"61","author":"Bellamy","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.019_bb0295","series-title":"Chronotherapeutics","first-page":"212","article-title":"Rhythms, pain and pain management","author":"Labrecque","year":"2003"},{"key":"10.1016\/j.ejim.2013.03.019_bb0300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0003-9969(92)90076-K","article-title":"Methionine enkephalin-like, substance P-like, and beta-endorphin-like immunoreactivity in human parotid saliva","volume":"37","author":"Pikula","year":"1992","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/030089168807400320","article-title":"Alteration of opioid peptide circadian rhythm in cancer patients","volume":"74","author":"Barni","year":"1988","journal-title":"Tumori"},{"key":"10.1016\/j.ejim.2013.03.019_bb0310","first-page":"99","article-title":"Circadian variation of potency of placebo as analgesic","volume":"2","author":"P\u00f6llmann","year":"1987","journal-title":"Funct Neurol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0315","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2125.1985.tb02726.x","article-title":"Chronopharmacokinetics of paracetamol in normal subjects","volume":"19","author":"Malan","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0320","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03190458","article-title":"Chronopharmacokinetics of acetaminophen in healthy human volunteers","volume":"27","author":"Kolawole","year":"2002","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ejim.2013.03.019_bb0325","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198712050-00003","article-title":"Circadian changes in the pharmacokinetics of oral ketoprofen","volume":"12","author":"Ollagnier","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejim.2013.03.019_bb0330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/07420529409055898","article-title":"Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis","volume":"11","author":"Perpoint","year":"1994","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00615406","article-title":"Circadian changes in the bioavailability and effects of indomethacin in healthy subjects","volume":"20","author":"Clench","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.1985.15","article-title":"Timing optimizes sustained-release indomethacin treatment of osteoarthritis","volume":"37","author":"Levi","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07420528709078514","article-title":"Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man","volume":"4","author":"Moore","year":"1987","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(08)60132-4","article-title":"Efficacy of modified release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial","volume":"371","author":"Buttgereit","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.03.019_bb0355","first-page":"49","article-title":"Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity","volume":"2","author":"Graves","year":"1983","journal-title":"Clin Pharm"},{"key":"10.1016\/j.ejim.2013.03.019_bb0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0304-3959(92)90236-5","article-title":"Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report","volume":"49","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2013.03.019_bb0365","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1358\/mf.2000.22.10.802293","article-title":"Circadian distribution of oral opioid consumption in cancer patients","volume":"22","author":"Klepstad","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0370","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00003246-200101000-00021","article-title":"Circadian differences in the individual sensitivity to opiate overdose","volume":"29","author":"Gallerani","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2013.03.019_bb0375","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)00204-R","article-title":"Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution","volume":"6","author":"Gourlay","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2013.03.019_bb0380","first-page":"183","article-title":"Opioid chronopharmacology: influence of timing of infusion on fentanyl's analgesic efficacy in healthy human volunteers","volume":"3","author":"Boom","year":"2010","journal-title":"J Pain Res"},{"key":"10.1016\/j.ejim.2013.03.019_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/07420529509064501","article-title":"Analgesic effects of dihydrocodeine and tramadol when administered either in the morning or evening","volume":"12","author":"Hummel","year":"1995","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ejim.2013.03.019_bb0390","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gut.29.11.1583","article-title":"Pattern of 24hour intragastric acidity in active duodenal ulcer disease and in healthy controls","volume":"29","author":"Merki","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2013.03.019_bb0395","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors","volume":"93","author":"Peghini","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2036.1992.tb00059.x","article-title":"Night-time or morning dosing with H2-receptor antagonists: studies on acid inhibition in normal subjects","volume":"6","author":"Patel","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0405","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000200686","article-title":"Single morning and nightly doses of ranitidine 300mg: an appraisal of their antisecretory effects by continuous pH monitoring","volume":"48","author":"Savarino","year":"1991","journal-title":"Digestion"},{"key":"10.1016\/j.ejim.2013.03.019_bb0410","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.1992.tb00057.x","article-title":"The effects of lansoprazole, a new H+, K(+)-ATPase inhibitor, on gastric pH and serum gastrin","volume":"6","author":"Sanders","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0415","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2036.1996.33175000.x","article-title":"Morning versus evening dosing of lansoprazole 30mg daily on twenty-four-hour intragastric acidity in healthy subjects","volume":"10","author":"Fraser","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2036.1992.tb00550.x","article-title":"Omeprazole (20mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration","volume":"6","author":"Chiverton","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0425","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00042737-199706000-00009","article-title":"Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH","volume":"9","author":"M\u00fcssig","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0430","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2036.2006.02781.x","article-title":"Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study","volume":"23","author":"Thomson","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.03.019_bb0435","first-page":"234","article-title":"The chronobiology and chronopharmacology of allergy","volume":"47","author":"Smolensky","year":"1981","journal-title":"Ann Allergy"},{"key":"10.1016\/j.ejim.2013.03.019_bb0440","first-page":"333","article-title":"Circadian timing of methylprednisolone effects in asthmatic boys","volume":"1","author":"Reinberg","year":"1974","journal-title":"Chronobiologia"},{"key":"10.1016\/j.ejim.2013.03.019_bb0445","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm\/146.6.1524","article-title":"Timing of prednisone and alterations of airways inflammation in nocturnal asthma","volume":"146","author":"Beam","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ejim.2013.03.019_bb0450","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0091-6749(95)70073-0","article-title":"Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy","volume":"95","author":"Pincus","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0455","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1378\/chest.105.6.1732","article-title":"Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma","volume":"105","author":"Gagnon","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2013.03.019_bb0460","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1345\/aph.1G410","article-title":"Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma","volume":"39","author":"Karpel","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2013.03.019_bb0465","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s002280000134","article-title":"A randomized controlled assessment of the systemic activity of budesonide when given once or twice daily via Turbuhaler","volume":"56","author":"Thorsson","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0470","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1398-9995.1994.tb00782.x","article-title":"Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies","volume":"49","author":"Faurschou","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.ejim.2013.03.019_bb0475","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1183\/09031936.96.09081684","article-title":"Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action","volume":"9","author":"van Noord","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2013.03.019_bb0480","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2005.04.012","article-title":"The 24h duration of bronchodilator action of the budesonide\/formoterol combination inhaler","volume":"100","author":"Masoli","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2013.03.019_bb0485","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/thorax.58.10.855","article-title":"Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2013.03.019_bb0490","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0091-6749(98)70054-5","article-title":"A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group","volume":"102","author":"Altman","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2013.03.019_bb0495","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ppul.20377","article-title":"Montelukast administered in the morning or evening to prevent exercise-induced bronchoconstriction in children","volume":"41","author":"Pajaron-Fernandez","year":"2006","journal-title":"Pediatr Pulmonol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T10:48:57Z","timestamp":1715251737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0953620513001039"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.019","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circadian rhythms and medical diseases: Does it matter when drugs are taken?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}